Abstract:Ifh1p and Crf1p are recruited to a conserved site in UTP22 and HMO1 promoters, and both proteins function as an activator. Inhibition of mTORC1 leads to depletion of Ifh1p and accumulation of Crf1p. Under stress conditions, ribosome biogenesis is downregulated. This process requires that expression of ribosomal RNA, ribosomal protein, and ribosome biogenesis genes be controlled in a coordinated fashion. The mechanistic Target of Rapamycin Complex 1 (mTORC1) participates in sensing unfavorable conditions to effect the requisite change in gene expression. In Saccharomyces cerevisiae, downregulation of ribosomal protein genes involves dissociation of the activator Ifh1p in a process that depends on Utp22p, a protein that also functions in pre‐rRNA processing. Ifh1p has a paralog, Crf1p, which was implicated in communicating mTORC1 inhibition and hence was perceived as a repressor. We focus here on two ribosomal biogenesis genes, encoding Utp22p and the high mobility group protein Hmo1p, both of which are required for communication of mTORC1 inhibition to target genes. Crf1p functions as an activator on these genes as evidenced by reduced mRNA abundance and RNA polymerase II occupancy in a crf1Δ strain. Inhibition of mTORC1 has distinct effects on expression of HMO1 and UTP22; for example, on UTP22, but not on HMO1, the presence of Crf1p promotes the stable depletion of Ifh1p. Our data suggest that Crf1p functions as a weak activator, and that it may be required to prevent re‐binding of Ifh1p to some gene promoters after mTORC1 inhibition in situations when Ifh1p is available. We propose that the inclusion of genes encoding proteins required for mTORC1‐mediated downregulation of ribosomal protein genes in the same regulatory circuit as the ribosomal protein genes serves to optimize transcriptional responses during mTORC1 inhibition.

Impairing the production of ribosomal RNA activates mammalian target of rapamycin complex 1 signalling and downstream translation factors

Autophagy Regulates Rrna Synthesis

Targeted Profiling of RNA Translation Reveals Mtor-4Ebp1/2-independent Translation Regulation of Mrnas Encoding Ribosomal Proteins.

Activating transcription factor 4-dependent hsa-miR-663a transcription mediates mTORC1/p70S6K1 signaling underleucine deprivation

Activating transcription factor 4-dependent hsa-miR-663a transcription mediates mTORC1/p70S6K1 signaling underleucine deprivation.

Requirement of the Mtor Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells

The Mammalian Target of Rapamycin in Translation and Folding

Coordination of Ribosomal Protein and Ribosomal RNA Gene Expression in Response to TOR Signaling

mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide

Phosphoproteome Profiling Revealed The Importance Of Mtor Inhibition On Cdk1 Activation To Further Regulate Cell Cycle Progression

Relaxed Initiation Pausing of Ribosomes Drives Oncogenic Translation

Intricate regulation of ribosome biogenesis genes in response to mTORC1 signaling

Reciprocal regulation of mTORC1 signaling and ribosomal biosynthesis determines cell cycle progression in activated T cells

Coordinate Regulation of Ribosome and tRNA Biogenesis Controls Hypoxic Injury and Translation

mTOR coordinates protein synthesis, mitochondrial activity and proliferation

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3 -mediated non-degradative ubiquitination of eIF4A1

Mtorc1-Rps15 Axis Contributes to the Mechanisms Underlying Global Translation Reduction During Senescence of Mouse Embryonic Fibroblasts

Deficiency in Mtorc1-Controlled C/Ebp Beta-Mrna Translation Improves Metabolic Health in Mice

Yeast Crf1p is an activator with different roles in regulation of target genes

Mtor Inhibition Activates Overall Protein Degradation by the Ubiquitin Proteasome System As Well As by Autophagy

mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3 IBTK -mediated ubiquitination of eIF4A1 in cancer cells